In vivo biomarkers of <scp>GABA</scp>ergic function in epileptic rats treated with the <scp>GAT</scp>‐1 inhibitor <scp>E2730</scp>

This study identified clinically relevant changes in multimodality imaging and functional purported biomarkers of GABAergic activity during E2730 treatment in epileptic and healthy control animals. These biomarkers could be utilized in clinical trials of E2730 and potentially other GABAergic drugs to provide surrogate endpoints, thereby reducing the cost of such trials.

Authors

Institutions

Publication Details

Journal
Epilepsia
Published
2024-09-20
DOI
https://doi.org/10.1111/epi.18119
Citations
5
Primary Topic
Neuroscience and Neuropharmacology Research
Type
article
Field-Weighted Citation Impact
1.34

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In vivo biomarkers of GABAergic function in epileptic rats treated with the GAT‐1 inhibitor E2730

Kazuyuki Fukushima, Terence John O'Brien, Brendan P. Major, Idrish Ali et al.
5 citations
Epilepsia
Neuroscience and Neuropharmacology Research
1.34
article

In vivo biomarkers of GABAergic function in epileptic rats treated with the GAT‐1 inhibitor E2730

Kazuyuki Fukushima, Terence John O'Brien, Brendan P. Major, Idrish Ali, Nigel C. Jones, Mohammad B. Haskali, Perminder Singh Sachdev, Peravina Thergarajan, Juliana Silva, Richelle Mychasiuk, Lucy E. Vivash, Robert Brkljača, Patrick Kwan, Jocelyn Y. Cheng, Pablo M. Casillas‐Espinosa, David Wright, Sandy R. Shultz, Glenn R. Yamakawa, Bianca Jupp, Emma L. Braine, Matthew R. Hudson
article en
5 citations

Abstract

This study identified clinically relevant changes in multimodality imaging and functional purported biomarkers of GABAergic activity during E2730 treatment in epileptic and healthy control animals. These biomarkers could be utilized in clinical trials of E2730 and potentially other GABAergic drugs to provide surrogate endpoints, thereby reducing the cost of such trials.

EpilepsiaVol. 65(11)
The University of Melbourne (AU), Peter MacCallum Cancer Centre (AU), Vancouver Island University (CA), Alfred Health (AU), Eisai (Japan) (JP), Monash University (AU)
U.S. Department of Defense, Eisai, Medical Research Council, National Health and Medical Research Council
Good health and well-being
Openalex Percentile: Top 20%
Neuroscience and Neuropharmacology Research
1.34
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.